Biotechnology
Compare Stocks
2 / 10Stock Comparison
CDT vs HRZN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
CDT vs HRZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Asset Management |
| Market Cap | $368K | $199M |
| Revenue (TTM) | $696M | $40M |
| Net Income (TTM) | $17M | $28M |
| Gross Margin | 36.9% | 18.0% |
| Operating Margin | 6.4% | -4.0% |
| Forward P/E | 0.0x | 6.1x |
| Total Debt | $1.29B | $473M |
| Cash & Equiv. | $390M | $106M |
CDT vs HRZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 100 | 0.0 | -100.0% |
| Horizon Technology … (HRZN) | 100 | 32.4 | -67.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDT vs HRZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 1.84
- Lower volatility, beta 1.84, current ratio 1.93x
- 8.9% revenue growth vs HRZN's 17.9%
HRZN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 17.9%, EPS growth 7.6%
- 52.9% 10Y total return vs CDT's -100.0%
- Beta 0.70, yield 27.8%, current ratio 1.24x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% revenue growth vs HRZN's 17.9% | |
| Value | Lower P/E (0.0x vs 6.1x) | |
| Quality / Margins | 2.4% margin vs HRZN's -6.6% | |
| Stability / Safety | Beta 0.70 vs CDT's 1.84 | |
| Dividends | 27.8% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -23.2% vs CDT's -99.8% | |
| Efficiency (ROA) | 3.6% ROA vs CDT's 1.0%, ROIC -0.2% vs 21.9% |
CDT vs HRZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CDT vs HRZN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CDT leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CDT is the larger business by revenue, generating $696M annually — 17.4x HRZN's $40M. CDT is the more profitable business, keeping 2.4% of every revenue dollar as net income compared to HRZN's -6.6%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $696M | $40M |
| EBITDAEarnings before interest/tax | $47M | $19M |
| Net IncomeAfter-tax profit | $17M | $28M |
| Free Cash FlowCash after capex | -$6M | $67M |
| Gross MarginGross profit ÷ Revenue | +36.9% | +18.0% |
| Operating MarginEBIT ÷ Revenue | +6.4% | -4.0% |
| Net MarginNet income ÷ Revenue | +2.4% | -6.6% |
| FCF MarginFCF ÷ Revenue | -0.9% | +141.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.4% | -29.6% |
Valuation Metrics
CDT leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 0.0x trailing earnings, CDT trades at a 100% valuation discount to HRZN's 4.3x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $367,825 | $199M |
| Enterprise ValueMkt cap + debt − cash | $896M | $567M |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | 4.30x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.10x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.18x |
| EV / EBITDAEnterprise value multiple | 2.43x | — |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 4.97x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.60x |
| Price / FCFMarket cap ÷ FCF | — | 3.51x |
Profitability & Efficiency
HRZN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HRZN delivers a 9.0% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $3 for CDT. CDT carries lower financial leverage with a 1.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HRZN's 1.49x. On the Piotroski fundamental quality scale (0–9), CDT scores 6/9 vs HRZN's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +2.6% | +9.0% |
| ROA (TTM)Return on assets | +1.0% | +3.6% |
| ROICReturn on invested capital | +21.9% | -0.2% |
| ROCEReturn on capital employed | +22.2% | -0.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.02x | 1.49x |
| Net DebtTotal debt minus cash | $896M | $368M |
| Cash & Equiv.Liquid assets | $390M | $106M |
| Total DebtShort + long-term debt | $1.3B | $473M |
| Interest CoverageEBIT ÷ Interest expense | -1.05x | 0.60x |
Total Returns (Dividends Reinvested)
HRZN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HRZN five years ago would be worth $6,724 today (with dividends reinvested), compared to $0 for CDT. Over the past 12 months, HRZN leads with a -23.2% total return vs CDT's -99.8%. The 3-year compound annual growth rate (CAGR) favors HRZN at -10.3% vs CDT's -97.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -94.2% | -26.7% |
| 1-Year ReturnPast 12 months | -99.8% | -23.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | -27.7% |
| 5-Year ReturnCumulative with dividends | -100.0% | -32.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +52.9% |
| CAGR (3Y)Annualised 3-year return | -97.4% | -10.3% |
Risk & Volatility
HRZN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HRZN is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than CDT's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HRZN currently trades 53.3% from its 52-week high vs CDT's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 0.70x |
| 52-Week HighHighest price in past year | $1425.00 | $8.46 |
| 52-Week LowLowest price in past year | $1.20 | $3.80 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +53.3% |
| RSI (14)Momentum oscillator 0–100 | 27.2 | 58.5 |
| Avg Volume (50D)Average daily shares traded | 126K | 1.2M |
Analyst Outlook
CDT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
HRZN is the only dividend payer here at 27.80% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $6.50 |
| # AnalystsCovering analysts | — | 22 |
| Dividend YieldAnnual dividend ÷ price | — | +27.8% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $1.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +28.8% | 0.0% |
CDT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HRZN leads in 3 (Profitability & Efficiency, Total Returns).
CDT vs HRZN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CDT or HRZN a better buy right now?
CDT Equity Inc.
(CDT) offers the better valuation at 0. 0x trailing P/E, making it the more compelling value choice. Analysts rate Horizon Technology Finance Corporation (HRZN) a "Hold" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDT or HRZN?
On trailing P/E, CDT Equity Inc.
(CDT) is the cheapest at 0. 0x versus Horizon Technology Finance Corporation at 4. 3x.
03Which is the better long-term investment — CDT or HRZN?
Over the past 5 years, Horizon Technology Finance Corporation (HRZN) delivered a total return of -32.
8%, compared to -100. 0% for CDT Equity Inc. (CDT). Over 10 years, the gap is even starker: HRZN returned +52. 9% versus CDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDT or HRZN?
By beta (market sensitivity over 5 years), Horizon Technology Finance Corporation (HRZN) is the lower-risk stock at 0.
70β versus CDT Equity Inc. 's 1. 84β — meaning CDT is approximately 162% more volatile than HRZN relative to the S&P 500. On balance sheet safety, CDT Equity Inc. (CDT) carries a lower debt/equity ratio of 102% versus 149% for Horizon Technology Finance Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CDT or HRZN?
On earnings-per-share growth, the picture is similar: Horizon Technology Finance Corporation grew EPS 756.
3% year-over-year, compared to 128. 8% for CDT Equity Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDT or HRZN?
CDT Equity Inc.
(CDT) is the more profitable company, earning 8. 7% net margin versus -6. 6% for Horizon Technology Finance Corporation — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CDT leads at 11. 6% versus -4. 0% for HRZN. At the gross margin level — before operating expenses — CDT leads at 38. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — CDT or HRZN?
In this comparison, HRZN (27.
8% yield) pays a dividend. CDT does not pay a meaningful dividend and should not be held primarily for income.
08Is CDT or HRZN better for a retirement portfolio?
For long-horizon retirement investors, Horizon Technology Finance Corporation (HRZN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
70), 27. 8% yield). CDT Equity Inc. (CDT) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HRZN: +52. 9%, CDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CDT and HRZN?
These companies operate in different sectors (CDT (Healthcare) and HRZN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CDT is a small-cap deep-value stock; HRZN is a small-cap high-growth stock. HRZN pays a dividend while CDT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 8%
- Dividend Yield > 11.1%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.